PHP
Parkman Healthcare Partners Portfolio holdings
AUM
$864M
This Quarter Return
+2.69%
1 Year Return
+33.7%
3 Year Return
+258.24%
5 Year Return
+878.92%
10 Year Return
–
AUM
$734M
AUM Growth
+$734M
(-9.9%)
Cap. Flow
-$47.7M
Cap. Flow
% of AUM
-6.5%
Top 10 Holdings %
Top 10 Hldgs %
35.85%
Holding
111
New
11
Increased
44
Reduced
34
Closed
21
Top Buys
| 1 |
Agios Pharmaceuticals
AGIO
|
$19.2M |
| 2 |
Insulet
PODD
|
$17.8M |
| 3 |
Icon
ICLR
|
$11.6M |
| 4 |
Humana
HUM
|
$11.2M |
| 5 |
Boston Scientific
BSX
|
$9.71M |
Top Sells
| 1 |
Tenet Healthcare
THC
|
$17.9M |
| 2 |
Inspire Medical Systems
INSP
|
$17.4M |
| 3 |
SILK
Silk Road Medical, Inc. Common Stock
SILK
|
$15.6M |
| 4 |
Cencora
COR
|
$13.5M |
| 5 |
Oscar Health
OSCR
|
$12.4M |
Sector Composition
| 1 | Healthcare | 99.93% |
| 2 | Industrials | 0.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Annexon
ANNX
$225M
| $1.6M | 0.21% |
326,845
-19,842
| -6% | -$97.2K |
|
77
ESSA Pharma
EPIX
$11.2M
| $1.33M | 0.18% |
252,072
+377
| +0.1% | +$1.98K |
|
78
Ardelyx
ARDX
$1.57B
| $1.11M | 0.15% |
150,192
-49,808
| -25% | -$369K |
|
79
Viking Therapeutics
VKTX
$3.02B
| $1.08M | 0.14% |
20,372
-9,926
| -33% | -$526K |
|
|
AKYA
80
DELISTED
Akoya BioSciences
AKYA
| $879K | 0.12% |
375,536
-541,906
| -59% | -$1.27M |
|
81
Eton Pharmaceutcials
ETON
$468M
| $833K | 0.11% |
253,197
+54,029
| +27% | +$178K |
|
82
Entera Bio
ENTX
$92.7M
| $739K | 0.1% |
+401,518
| New | +$739K |
|
83
VYNE Therapeutics
VYNE
$8.09M
| $680K | 0.09% |
345,206
-351,264
| -50% | -$692K |
|
84
Reviva Pharmaceuticals
RVPH
$31.3M
| $646K | 0.09% |
504,600
+746
| +0.1% | +$955 |
|
|
AUGX
85
DELISTED
Augmedix, Inc. Common Stock
AUGX
| $499K | 0.07% |
566,845
-499,264
| -47% | -$439K |
|
86
X4 Pharmaceuticals
XFOR
$70M
| $468K | 0.06% |
806,616
+1,257
| +0.2% | +$731 |
|
87
TELA Bio
TELA
$65.4M
| $460K | 0.06% |
97,816
+148
| +0.2% | +$696 |
|
88
Alpha Teknova
TKNO
$227M
| $406K | 0.05% |
296,652
+450
| +0.2% | +$616 |
|
89
Xeris Biopharma Holdings
XERS
$1.27B
| $227K | 0.03% |
100,830
+154
| +0.2% | +$347 |
|
|
DCPH
90
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| – | – |
-729,230
| Closed | -$11.5M |
|
|
SILK
91
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| – | – |
-848,897
| Closed | -$15.6M |
|
92
Thermo Fisher Scientific
TMO
$183B
| – | – |
-15,572
| Closed | -$9.05M |
|
93
SOPHiA GENETICS
SOPH
$232M
| – | – |
-209,896
| Closed | -$1.03M |
|
|
94
Oscar Health
OSCR
$4.57B
| – | – |
-831,283
| Closed | -$12.4M |
|
95
NovoCure
NVCR
$1.35B
| – | – |
-50,000
| Closed | -$782K |
|
96
Nkarta
NKTX
$149M
| – | – |
-252,028
| Closed | -$2.72M |
|
97
Merck
MRK
$210B
| – | – |
0
| – | – |
|
98
Lyra Therapeutics
LYRA
$11.8M
| – | – |
-642,245
| Closed | -$3.99M |
|
99
Standard BioTools
LAB
$493M
| – | – |
-1,670,401
| Closed | -$4.53M |
|
100
Disc Medicine
IRON
$2.14B
| – | – |
-107,593
| Closed | -$6.7M |
|